Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Bangkok study aims to reduce chemsex risks among gay men

NCT ID NCT07512869

Knowledge-focused Sponsor: Institute of HIV Research and Innovation Foundation, Thailand Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is gathering information from men who have sex with men who take part in chemsex (using drugs before or during sex) in Bangkok, Thailand. Researchers will survey party hosts and guests about their drug use, sexual health, mental health, and experiences of stigma. The goal is to understand their needs and design a harm reduction program led by the community.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a community-driven harm reduction program that reduces substance use and sexual health risks among men who have sex with men in Bangkok.
What could go wrong
This is a small, early-stage study (76 participants) focused on gathering information, not testing a treatment. The findings may not apply to other cities or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 76 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Recruit chemsex party hosts, chemsex party guests, representatives from the CSOs, government hospital, police organization G1: Chemsex party hosts 1. Have ever hosted a chemsex party at least 2 times in the past 6 months. G2: Chemsex party guests 1\. Have ever attended a chemsex party at least 2 times in the past 6 months. G3: CSOs 1. Currently working in a CSO 3. Hold a role or perform a duty related to chemsex-related incidents or drug use for more than 3 months. G4: Government hospitals 1. Currently working in a government hospital. 2. Hold a role or perform a duty related to chemsex-related incidents or drug use for more than 3 months. G5: Police officers 1\. Currently working in a police organization. 3. Hold a role or perform the duty related to chemsex-related incidents or drug use for more than 3 months.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * MSM aged ≥18 years * Able to communicate in Thai * Specific by group: * Chemsex hosts: hosted ≥2 times in past 6 months * Chemsex guests: attended ≥2 times in past 6 months * CSO / hospital / police staff: working ≥3 months in related roles * Provide informed consent Exclusion Criteria: • Unable to provide informed consent (e.g., under substance influence at consent)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV prevention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chemsex Harm Reduction Psychological Well-Being sexually transmitted disease substance abuse substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV prevention Mental health Sexually transmitted infections (STIS) Substance use

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Tangerine Clinic, Institute of HIV Research and Innovation

    RECRUITING

    Pathum Wan, Bangkok, 10330, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.